- Health care utilization and costs among privately insured patients with bipolar I disorderLynda Bryant-Comstock
GlaxoSmithKline Research and Development, Global Health Outcomes, Research Triangle Park, NC 27709, USA
Bipolar Disord 4:398-405. 2002..This study examined health care resource utilization and direct health care costs among patients diagnosed with bipolar I disorder in a privately insured population...
- Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysisMonika Stender
GlaxoSmithKline Research and Development, Greenford, Middlesex, United Kingdom
Clin Ther 24:1668-76. 2002..Detailed assessments of the direct costs related to bipolar disorder and of the burden it places on the health care system are limited...